Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1725 of 3546 entries
View as:

Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)

Phase: N/A Priority: Normal
NCT ID: NCT02567721 Org: User:
Start: 10/31/15 End: 11/30/15 Due: 11/30/16

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

Phase: N/A Priority: Normal
NCT ID: NCT01381601 Org: User:
Start: 03/31/11 End: 10/31/11 Due: 10/31/12

Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.

Phase: N/A Priority: Normal
NCT ID: NCT00422955 Org: User:
Start: 11/30/03 End: 10/31/05 Due: 10/31/06

A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

Phase: N/A Priority: Normal
NCT ID: NCT01977573 Org: User:
Start: 10/31/13 End: 06/15/15 Due: 06/15/16

Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00331058 Org: User:
Start: 02/18/06 End: 07/07/11 Due: 07/07/12

Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03306589 Org: User:
Start: 08/11/17 End: 06/20/18 Due: 06/20/19

A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT03258710 Org: User:
Start: 10/02/17 End: 11/25/19 Due: 11/25/20

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza

Phase: N/A Priority: Normal
NCT ID: NCT01231620 Org: User:
Start: 01/15/11 End: 03/18/15 Due: 03/18/16

Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)

Phase: N/A Priority: Normal
NCT ID: NCT01855711 Org: User:
Start: 09/18/03 End: 05/10/05 Due: 05/10/06

GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00950807 Org: User:
Start: 09/01/09 End: 03/15/10 Due: 03/15/11

Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants

Phase: N/A Priority: Normal
NCT ID: NCT00655187 Org: User:
Start: 04/30/08 End: 07/31/10 Due: 07/31/11

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00650910 Org: User:
Start: 04/23/08 End: 07/10/09 Due: 07/10/10

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

Phase: N/A Priority: Normal
NCT ID: NCT00527605 Org: User:
Start: 10/31/07 End: 03/31/09 Due: 03/31/10

Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT01978093 Org: User:
Start: 02/01/14 End: 03/18/16 Due: 03/18/17

Study of GSK1363089 in Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00725712 Org: User:
Start: 03/31/07 End: 11/30/09 Due: 11/30/10

A Study of GW685698X in Healthy Japanese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00972673 Org: User:
Start: 09/24/08 End: 12/19/08 Due: 12/19/09

Lamotrigine Extended-Release In Elderly Patients With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00516139 Org: User:
Start: 08/31/07 End: 07/31/10 Due: 07/31/11

A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01277692 Org: User:
Start: 11/03/10 End: 05/09/11 Due: 05/09/12

Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00833378 Org: User:
Start: 01/19/09 End: 03/11/09 Due: 03/11/10

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03207750 Org: User:
Start: 09/14/17 End: 03/01/19 Due: 03/01/20

Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension

Phase: N/A Priority: Normal
NCT ID: NCT00246636 Org: User:
Start: 10/31/05 End: 03/31/07 Due: 03/31/08

An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy

Phase: N/A Priority: Normal
NCT ID: NCT01332539 Org: User:
Start: 05/31/11 End: 11/30/12 Due: 11/30/13

A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.

Phase: N/A Priority: Normal
NCT ID: NCT00405119 Org: User:
Start: 05/31/06 End: 03/31/07 Due: 03/31/08

A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions

Phase: N/A Priority: Normal
NCT ID: NCT01476215 Org: User:
Start: 11/30/09 End: 11/30/09 Due: 11/30/10

Prophylactic Efficacy of Relenza Against Influenza A and B

Phase: N/A Priority: Normal
NCT ID: NCT01156701 Org: User:
Start: 07/31/09 End: 05/31/10 Due: 05/31/11